(CDE) Coeur Mining - Overview
Stock: Gold, Silver, Zinc, Lead, Concentrates
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 85.0% |
| Relative Tail Risk | -10.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.87 |
| Alpha | 182.90 |
| Character TTM | |
|---|---|
| Beta | 1.334 |
| Beta Downside | 1.221 |
| Drawdowns 3y | |
|---|---|
| Max DD | 54.63% |
| CAGR/Max DD | 1.55 |
Description: CDE Coeur Mining January 09, 2026
Coeur Mining, Inc. (NYSE:CDE) is a mid-tier precious-metals producer headquartered in Chicago, operating mines in the United States, Canada, and Mexico. The firm’s primary assets are organized into seven segments-Palmarejo (Mexico), Rochester (Nevada), Kensington (Alaska), Wharf (Alaska), Silvertip (Idaho), and Las Chispas (Mexico)-which together generate most of its gold and silver output.
Beyond extracting gold and silver, Coeur actively explores for zinc, lead, and other base metals, and it sells its concentrates to third-party refiners and smelters under off-take agreements that help lock in revenue streams. The company, originally incorporated in 1928 as Coeur d’Alene Mines Corporation, rebranded to Coeur Mining in May 2013.
Recent performance metrics (2023) show approximately 1.2 million ounces of silver and 150,000 ounces of gold produced, with a cash cost of roughly $12 per ounce of silver and $950 per ounce of gold. Net earnings were $140 million, and the balance sheet remains modestly leveraged at a debt-to-EBITDA ratio of 1.8×, giving the firm flexibility to fund exploration and potential acquisitions.
Key economic drivers for Coeur include the price trajectory of silver-currently hovering around $24/oz, which is a primary determinant of cash flow-and gold price movements, which affect the valuation of its by-product gold. Additionally, inflation-driven labor and energy costs in North America, as well as the broader demand for industrial metals (zinc, lead) tied to global infrastructure spending, influence the company’s margin outlook.
For a deeper, data-driven assessment of Coeur’s valuation and risk profile, you may find ValueRay’s analytical tools useful.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 408.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 10.52 > 1.0 |
| NWC/Revenue: 9.23% < 20% (prev 2.76%; Δ 6.47% < -1%) |
| CFO/TA 0.13 > 3% & CFO 576.1m > Net Income 408.8m |
| Net Debt (110.2m) to EBITDA (695.4m): 0.16 < 3 |
| Current Ratio: 1.47 > 1.5 & < 3 |
| Outstanding Shares: last quarter (650.8m) vs 12m ago 62.36% < -2% |
| Gross Margin: 49.11% > 18% (prev 0.31%; Δ 4880 % > 0.5%) |
| Asset Turnover: 50.47% > 50% (prev 45.37%; Δ 5.10% > 0%) |
| Interest Coverage Ratio: 12.68 > 6 (EBITDA TTM 695.4m / Interest Expense TTM 36.9m) |
Altman Z'' -2.77
| A: 0.03 (Total Current Assets 490.7m - Total Current Liabilities 333.8m) / Total Assets 4.51b |
| B: -0.60 (Retained Earnings -2.69b / Total Assets 4.51b) |
| C: 0.14 (EBIT TTM 467.4m / Avg Total Assets 3.37b) |
| D: -1.89 (Book Value of Equity -2.68b / Total Liabilities 1.42b) |
| Altman-Z'' Score: -2.77 = D |
Beneish M -0.24
| DSRI: 1.33 (Receivables 67.7m/30.2m, Revenue 1.70b/1.01b) |
| GMI: 0.63 (GM 49.11% / 30.75%) |
| AQI: 5.04 (AQ_t 0.28 / AQ_t-1 0.05) |
| SGI: 1.68 (Revenue 1.70b / 1.01b) |
| TATA: -0.04 (NI 408.8m - CFO 576.1m) / TA 4.51b) |
| Beneish M-Score: -0.24 (Cap -4..+1) = D |
What is the price of CDE shares?
Over the past week, the price has changed by +4.89%, over one month by +9.22%, over three months by +48.48% and over the past year by +208.49%.
Is CDE a buy, sell or hold?
- StrongBuy: 3
- Buy: 6
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CDE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 25.4 | 18.6% |
| Analysts Target Price | 25.4 | 18.6% |
| ValueRay Target Price | 26.7 | 24.7% |
CDE Fundamental Data Overview February 04, 2026
P/E Forward = 9.3721
P/S = 7.673
P/B = 4.2423
P/EG = -1.18
Revenue TTM = 1.70b USD
EBIT TTM = 467.4m USD
EBITDA TTM = 695.4m USD
Long Term Debt = 290.6m USD (from longTermDebt, last quarter)
Short Term Debt = 37.9m USD (from shortTermDebt, last quarter)
Debt = 376.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 110.2m USD (from netDebt column, last quarter)
Enterprise Value = 13.16b USD (13.05b + Debt 376.6m - CCE 266.3m)
Interest Coverage Ratio = 12.68 (Ebit TTM 467.4m / Interest Expense TTM 36.9m)
EV/FCF = 35.71x (Enterprise Value 13.16b / FCF TTM 368.5m)
FCF Yield = 2.80% (FCF TTM 368.5m / Enterprise Value 13.16b)
FCF Margin = 21.67% (FCF TTM 368.5m / Revenue TTM 1.70b)
Net Margin = 24.03% (Net Income TTM 408.8m / Revenue TTM 1.70b)
Gross Margin = 49.11% ((Revenue TTM 1.70b - Cost of Revenue TTM 865.5m) / Revenue TTM)
Gross Margin QoQ = 55.15% (prev 50.11%)
Tobins Q-Ratio = 2.92 (Enterprise Value 13.16b / Total Assets 4.51b)
Interest Expense / Debt = 1.67% (Interest Expense 6.27m / Debt 376.6m)
Taxrate = 21.0% (US default 21%)
NOPAT = 369.3m (EBIT 467.4m * (1 - 21.00%))
Current Ratio = 1.47 (Total Current Assets 490.7m / Total Current Liabilities 333.8m)
Debt / Equity = 0.12 (Debt 376.6m / totalStockholderEquity, last quarter 3.09b)
Debt / EBITDA = 0.16 (Net Debt 110.2m / EBITDA 695.4m)
Debt / FCF = 0.30 (Net Debt 110.2m / FCF TTM 368.5m)
Total Stockholder Equity = 2.45b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.13% (Net Income 408.8m / Total Assets 4.51b)
RoE = 16.69% (Net Income TTM 408.8m / Total Stockholder Equity 2.45b)
RoCE = 17.07% (EBIT 467.4m / Capital Employed (Equity 2.45b + L.T.Debt 290.6m))
RoIC = 13.12% (NOPAT 369.3m / Invested Capital 2.82b)
WACC = 10.56% (E(13.05b)/V(13.43b) * Re(10.83%) + D(376.6m)/V(13.43b) * Rd(1.67%) * (1-Tc(0.21)))
Discount Rate = 10.83% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 30.78%
[DCF Debug] Terminal Value 62.18% ; FCFF base≈368.5m ; Y1≈266.6m ; Y5≈147.8m
Fair Price DCF = 2.84 (EV 1.93b - Net Debt 110.2m = Equity 1.82b / Shares 642.1m; r=10.56% [WACC]; 5y FCF grow -32.57% → 2.90% )
[DCF Warning] FCF declining rapidly (-32.57%), DCF may be unreliable
EPS Correlation: 76.96 | EPS CAGR: 10.03% | SUE: -4.0 | # QB: 0
Revenue Correlation: 84.00 | Revenue CAGR: 29.91% | SUE: 0.15 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.19 | Chg30d=-0.095 | Revisions Net=+2 | Analysts=1
EPS next Year (2026-12-31): EPS=1.75 | Chg30d=+0.307 | Revisions Net=+2 | Growth EPS=+90.4% | Growth Revenue=+26.9%